GlobeNewswire: Amyris, Inc. Contains the last 10 of 276 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T15:20:56ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2019/05/24/1848170/0/en/Amyris-Appoints-Two-New-Board-Members-with-Significant-Experience-in-Building-High-Growth-Product-and-Consumer-Companies.html?f=22&fvtc=4&fvtv=15038Amyris Appoints Two New Board Members with Significant Experience in Building High Growth Product and Consumer Companies2019-05-24T12:30:00Z<![CDATA[EMERYVILLE, Calif., May 24, 2019 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced the appointment of two new board members, Jim McCann, founder and chairman of 1-800-Flowers, and Lisa Qi, founder and CEO of Daling Family Company in China. McCann and Qi are experts in ramping product sales and managing growth.]]>https://www.globenewswire.com/news-release/2019/05/23/1841539/0/en/Amyris-Teams-Up-with-Model-and-Businesswoman-Rosie-Huntington-Whiteley-as-Brand-Partner-for-its-Pipette-Baby-Brand.html?f=22&fvtc=4&fvtv=15038Amyris Teams Up with Model and Businesswoman Rosie Huntington-Whiteley as Brand Partner for its Pipette Baby Brand2019-05-23T12:30:00Z<![CDATA[EMERYVILLE, Calif., May 23, 2019 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that Rosie Huntington-Whiteley, the British supermodel, designer, businesswoman, and mother, is joining Amyris’s Pipette baby brand as its new brand partner to drive awareness and sales. Huntington-Whiteley will also serve on Pipette’s advisory board to help guide the brand to meet the needs of parents through clean, effective, and sustainable baby care products.]]>Rosie Huntington-Whiteley, Brand Partner for Pipette Baby BrandRosie Huntington-Whiteley, Brand Partner for Pipette Baby Brandhttps://www.globenewswire.com/news-release/2019/05/21/1833706/0/en/Amyris-to-Present-at-B-Riley-FBR-20th-Annual-Institutional-Investor-Conference-on-Thursday-May-23-2019.html?f=22&fvtc=4&fvtv=15038Amyris to Present at B. Riley FBR 20th Annual Institutional Investor Conference on Thursday, May 23, 20192019-05-21T18:00:00Z<![CDATA[EMERYVILLE, Calif., May 21, 2019 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that management will be presenting at the B. Riley FBR 20th Annual Institutional Investor Conference May 22-23, at the Beverly Hilton Hotel in Beverly Hills, California.]]>https://www.globenewswire.com/news-release/2019/05/21/1833377/0/en/Amyris-Announces-the-Execution-of-Strategic-Supply-Agreements-with-Ra%C3%ADzen-the-Largest-Sugar-Producer-in-the-World.html?f=22&fvtc=4&fvtv=15038Amyris Announces the Execution of Strategic Supply Agreements with Raízen, the Largest Sugar Producer in the World2019-05-21T12:30:00Z<![CDATA[EMERYVILLE, Calif., May 21, 2019 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced the execution of strategic supply agreements with Raízen for the supply of sugar, energy and other utilities to its new planned production plant co-located with Raízen’s Barra Mill at Barra Bonita, Brazil.]]>https://www.globenewswire.com/news-release/2019/05/20/1829202/0/en/Amyris-Receives-Notification-of-Deficiency-from-Nasdaq-Related-to-Delayed-Quarterly-Report-on-Form-10-Q.html?f=22&fvtc=4&fvtv=15038Amyris Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q2019-05-20T21:00:00Z<![CDATA[EMERYVILLE, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today reported that it has received a standard notice from Nasdaq stating that, as a result of not having timely filed its quarterly report on Form 10-Q for the quarter ended March 31, 2019, and because it remains delinquent in filing its annual report on Form 10-K for the year ended December 31, 2018, it is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic financing reports with the Securities and Exchange Commission.]]>https://www.globenewswire.com/news-release/2019/05/20/1827756/0/en/Amyris-Announces-Receipt-of-10-Million-Payment-from-LAVVAN-for-Delivering-on-First-Major-CBD-Milestone.html?f=22&fvtc=4&fvtv=15038Amyris Announces Receipt of $10 Million Payment from LAVVAN for Delivering on First Major CBD Milestone2019-05-20T12:30:00Z<![CDATA[EMERYVILLE, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today reported that it has received from its cannabinoid partner, LAVVAN, a first cash payment of $10 million for having successfully delivered on its first major collaboration milestone as announced on March 29, 2019.]]>https://www.globenewswire.com/news-release/2019/05/15/1825570/0/en/Amyris-Retires-May-2019-Convertible-Note-Debt.html?f=22&fvtc=4&fvtv=15038Amyris Retires May 2019 Convertible Note Debt2019-05-15T20:00:00Z<![CDATA[EMERYVILLE, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced that it has retired its 6.5% convertible notes due May 2019. The company retired the majority of the debt using cash and the exchange of certain notes for common stock and warrants. One of the noteholders, board-affiliated Total S.A., which holds about $9.7 million of the remaining notes, requested an extension and the company has paid this portion with a new note payable to Total.]]>https://www.globenewswire.com/news-release/2019/05/14/1824094/0/en/Amyris-to-Videocast-its-Exclusive-Annual-Industry-Forum-BioDisrupt-2019.html?f=22&fvtc=4&fvtv=15038Amyris to Videocast its Exclusive Annual Industry Forum – BioDisrupt 20192019-05-14T19:00:00Z<![CDATA[EMERYVILLE, Calif., May 14, 2019 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, will host its exclusive annual industry forum, BioDisrupt 2019, on May 16, 2019 at the company’s Emeryville headquarters. BioDisrupt will provide an update on the company’s business and demonstrate how biotechnology makes natural products sustainable and will explore industry trends and products with Amyris’s community of investors, partners, customers, and influencers.]]>https://www.globenewswire.com/news-release/2019/04/29/1811257/0/en/Amyris-Announces-Closing-of-34-Million-Private-Placement.html?f=22&fvtc=4&fvtv=15038Amyris Announces Closing of $34 Million Private Placement2019-04-29T12:30:00Z<![CDATA[EMERYVILLE, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leader in the development and production of sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, today announced the majority closing of, in total, a $34 million private placement of its common stock and warrants to purchase common stock with accredited investors with most funds received and the remainder to be received this week. The financing was anchored by long-term investors in the company.]]>https://www.globenewswire.com/news-release/2019/04/18/1806483/0/en/Amyris-Completes-Sale-of-Vitamin-E-Royalty-to-DSM.html?f=22&fvtc=4&fvtv=15038Amyris Completes Sale of Vitamin E Royalty to DSM2019-04-18T12:30:00Z<![CDATA[Exiting Vitamin E Simplifies Amyris and Improves Predictability Exiting Vitamin E Simplifies Amyris and Improves Predictability]]>